Glioblastoma Multiforme Clinical Trials in Seattle, Washington

4 studies are recruiting for glioblastoma multiforme in Seattle, Washington right now. Each one is listed on ClinicalTrials.gov, the public registry the research teams themselves file with. TrialBoost is not a doctor, a research site, or a study sponsor: the research team decides who takes part.

Search these by distance from you

Studies now recruiting

  1. Targeted Pediatric High-Grade Glioma Therapy

    The goal of this study is to perform genetic sequencing on brain tumors from children, adolescents, and young adult patients who have been newly diagnosed with a high-grade glioma. This molecular profiling will decide if patients are eligible to participate in a subsequent treatment-based clinical …

    Stage
    Not phased
    Ages
    1 to 39
    Site
    Seattle Children's Hospital, Seattle, Washington
    Locations
    22 in total
    Run by
    Nationwide Children's Hospital

    See if you can join NCT05839379 on ClinicalTrials.gov

  2. Radiation Combined With BIspecific T-Cell Engager in DLL3 Expressing Tumors

    Phase I study to examine safety of the addition of concurrent tarlatamab with standard palliative and consolidative RT regimens , with a main cohort of N=20-24 patients with extracranial anatomic radiation sites. I) After lead in of 10 patients demonstrating safety of treatment, allow for expansion…

    Stage
    Phase 1
    Ages
    18 to 99
    Site
    University of Washington Fred Hutchinson Cancer Center, Seattle, Washington
    Locations
    2 in total
    Run by
    University of Arizona

    See if you can join NCT06814496 on ClinicalTrials.gov

  3. Lorlatinib for Newly-Diagnosed High-Grade Glioma With ROS or ALK Fusion

    The goal of this study is to determine the response of the study drug loratinib in treating children who are newly diagnosed high-grade glioma with a fusion in ALK or ROS1. It will also evaluate the safety of lorlatinib when given with chemotherapy or after radiation therapy.

    Stage
    EARLY_Phase 1
    Ages
    1 to 21
    Site
    Seattle Children's Hospital, Seattle, Washington
    Locations
    18 in total
    Run by
    Nationwide Children's Hospital

    See if you can join NCT06333899 on ClinicalTrials.gov

  4. Study of Ribociclib and Everolimus in HGG and DIPG or Ribociclib and Temozolomide in DHG, H3G34-mutant

    The goal of this study is to determine the efficacy of the 1) ribociclib and everolimus to treat pediatric and young adult patients newly diagnosed with a high-grade glioma (HGG), including DIPG, that have genetic changes in pathways (cell cycle, PI3K/mTOR) that these drugs target or 2) ribociclib …

    Stage
    Phase 2
    Ages
    1 to 39
    Site
    Seattle Children's Hospital, Seattle, Washington
    Locations
    20 in total
    Run by
    Nationwide Children's Hospital

    See if you can join NCT05843253 on ClinicalTrials.gov

How to read this page. Every study here comes from ClinicalTrials.gov, the public registry that research teams are required to file with. We have summarised each one in plain language and shown where it is running. We have not changed what any study says it is doing.

What TrialBoost is. We help people find research that might suit them, and, if they ask us to, we pass their details to the research team running it. We are not a doctor, a research site, or a study sponsor, and we do not decide who takes part in anything. Joining costs nothing and you can change your mind at any point.

Paid placement. Some studies pay us when someone asks to be connected to them. Those are labelled Sponsored wherever they appear, and they only appear when they match what you were actually looking for.